Lobbying client · LD-2 disclosures
Sumitomo Pharma America (Formerly Sunovion Pharmaceuticals, Inc.)
Massachusetts
49 filings from 1 registrant · 2010–2024 · latest filed Apr 13, 2024
Reported on its behalf
$1.8M
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$1.8M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Pharmacy
PHA
43 filings
$1.7M on those filings
Health Issues
HCR
2 filings
$50K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- David Joseph Farber King & Spalding LLP46 filingsthrough 2024
- Scott Dziengelski King & Spalding LLPCovered position: Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017)18 filingsthrough 2024
- DANIEL F DONOVAN iii King & Spalding LLPCovered position: Senate Committees on Finance, Small Business, and Government Affairs14 filingsthrough 2016
- Patrick Morrisey King & Spalding LLPCovered position: Deputy Staff Director, House E&C Committee
The filings
The 20 most recent of 49 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: sumitomo-pharma-america-formerly-sunovion-pharmaceuticals-inc.